# Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer

> **NCT01284504** · NA · TERMINATED · sponsor: **Stanford University** · enrollment: 1 (actual)

## Conditions studied

- Colorectal Cancer
- Colon Cancer

## Interventions

- **DRUG:** Celecoxib
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01284504
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** low accrual rate; the only participant withdrew after signing consent
- **Last updated:** 2018-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01284504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01284504, "Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01284504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*